Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 20, 6-7 (2021)
doi: https://doi.org/10.1038/d41573-020-00220-y
Updates & Corrections
-
Clarification 17 December 2020: The description of the first agent from Codiak to enter clinical trials has been updated to ‘engineered exosome-based therapeutic’ to distinguish it from non-engineered exosome-based therapeutics, which are not the focus of the article.